H.6.Investigation: scope of issue: the scope of issue is only limited to facscalibur cytometer 3 color basic ivd part # 342973, serial # (b)(6).Problem statement: customer reported a complaint regarding erroneous results.Manufacturing defect trend: there are zero qns (quality notifications) related to the reported issue.Date range from 05nov2020 to date 05nov2021.Complaint trend: there are 2 complaints related to the issue of erroneous results.Date range from 05nov2020 to date 05nov2021.Manufacturing device history record (dhr) review: dhr part #342973 serial # (b)(6), file # 342973-342973-e34297300677-100520906-14, was reviewed.The instrument met all the manufacturing specifications prior to release.Investigation result / analysis: the investigation was performed and based on the review of the complaint trend, defect trend, dhr, risk analysis and servicemax, the root cause of the erroneous results could not be determined.The customer had initially reported that their instrument had been producing erroneous results.The tsr (technical service representative) sent the customer a quote for the repair since the instrument was out of warranty, and the customer rejected the repair.No repair was performed on this instrument at this time.Although the unexpected results were from patient samples who may be affected by an incorrect analysis of their samples, no patient was treated nor harmed from incorrect results.The results were captured prior to any diagnostic decision and these results were easily identified as erroneous.The safety risk is moderate, s3, and there was no impact to patient health or safety.Service max review: review of related work order #: n/a, case # (b)(4).Install date: 20jan2015.Defective part number: n/a.Case comments: out-of-warranty instrument, refused to pay for repair.Facscalibur-abnormal results.Clinical use.Clinical samples did not affect patient treatment.Returned sample evaluation: a return sample was not requested because there were no replaced parts.Risk analysis: risk management file part # 342973ra, rev.04/vers.D, bd facscalibur product family risk analysis was reviewed.No new hazards have been identified and the current mitigation is sufficient.Hazard(s) identified? yes, no.Id: 3.1.5 operational hazard ¿ fl3 separation qc failure.Hazard: instrument parameters not optimized.Cause: cannot proceed with clinical results after qc failure.Harmful effects: poor separation and gates do not work as desired leading to wrong result.Risk control: optimize instrument.Implementation verification: service bulletin: fcb-19-11 (fl3 sensitivity separation failure).Effectiveness verification: 1.Implementation of service bulletin via servicemax.Product tech support engineer performed effectively check via servicemax qo audit.Probability: 1.Severity: 3.Risk index: 3.Residual risk evaluation: a.New hazards: none.Mitigation(s) sufficient yes, no? root cause: based on the investigation results the root cause of the erroneous results could not be determined.Conclusion: based on the investigation results the root cause of the erroneous results could not be determined.The customer had initially reported that they observed abnormal results from their instrument, but also rejected the quote provided by the tsr on the cost of the repair.No repair was performed on this instrument at this time.No one was harmed or injured, and no medical diagnosis was performed due to the erroneous results.The safety risk is moderate, s3, and there was no impact to patient health or safety.H3 other text : see h.10.
|